In agreement with our earlier reports, it was observed that CD8+ T cells increase significantly in NLGP-treated tumor bearing mice (Fig 2A) and also in surgically sarcoma-removed NLGP immunized mice in comparison to PBS controls (Fig 2B). This evidence concerns the gene CD8A and sarcoma.